Home
Product
FDF
API
About Us
Profiles
Video
Honor
News
Contact Us
中
/
EN
Home
Product
FDF
API
About Us
Profiles
Video
Honor
News
Contact Us
Praprofen eye drops have been officially approved
Join hands with Xipu · Development increment Wanhan Pharmaceutical invites you to visit and negotiate
WANHAN PHARMACEUTICAL COMPANY: Praloflaxin API has been approved.
WANHAN PHARMACEUTICAL COMPANY: Bromfenac Sodium Eye Drops (Preservative-Free and Single-Dose) - 0.4ml/Unit has been officially approved.
WANHAN PHARMACEUTICAL COMPANY: Bromfenac Sodium Eye Drops has been authorized.
WANHAN PHARMACEUTICAL COMPANY: Sodium Hyaluronate Eye Drops (Preservative-Free and Single-Dose) - 0.4ml/Unit has been successfully approved.
WANHAN PHARMACEUTICAL COMPANY: Sodium Hyaluronate Eye Drops - 0.3% (5ml: 15mg) has been formally approved.
WANHAN PHARMACEUTICAL COMPANY: Moxifloxacin Hydrochloride Eye Drops (Preservative-Free and Single-Dose) - 0.4ml/Unit has been officially approved.
1
2
3
4
5